Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
1.00
0.03 (3.08%)
At close: Aug 15, 2025, 3:58 PM
1.00
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Akari Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.93M | -19.79M | -16.02M | -13.13M | -8.57M | -2.01M | -2.01M | -2.01M | -4.69M | -10.86M | -16.65M | -18.1M | -16.76M | -17.42M | -18.46M | -15.56M | -19.54M |
Depreciation & Amortization | 1K | 14K | 13K | 13K | 14.85K | 2.85K | 2.85K | 2.85K | 1.94K | 1.95K | 2.96K | 3.99K | 4.1K | 4.13K | 4.12K | 4.07K | 6.06K |
Stock-Based Compensation | 3.26M | 2.25M | 989.3K | 1.35K | 1.18K | 1.14K | 1.1K | 1.05K | 123.63K | 222.21K | 298.99K | 369.35K | 328.59K | 314.65K | 318.19K | 328.68K | 309.91K |
Other Working Capital | -55K | 1.54M | 534.00 | 1.6M | 1.1M | -1.06M | -1.06M | -1.06M | -3.52M | -2.85M | -1.95M | -2.13M | 298.12K | -1.74M | -2.64M | -2.46M | -1.93M |
Other Non-Cash Items | 3.5M | 3.46M | 4.61M | 2.6M | -3.12M | -8.38M | -8.38M | -8.38M | -5.38M | -142.41K | -90.25K | -88.62K | -105.34K | 242.5K | 43.61K | -1.76M | 1.6M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 512K | 1.54M | 534.00 | 1.6M | 680.44K | -1.48M | -1.48M | -1.48M | -3.52M | -2.85M | -2.2M | -2.37M | 56.81K | -1.98M | 16.37K | -224.46K | 990.66K |
Operating Cash Flow | -10.66M | -12.55M | -10.43M | -8.94M | -13.62M | -14.46M | -14.46M | -14.46M | -13.46M | -13.63M | -18.63M | -20.19M | -16.48M | -18.85M | -18.08M | -17.22M | -16.63M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -0.16 | -10.7K | -10.7K | -10.7K | -10.7K | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | -1.15M | -640K | 333K | 669K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.12M | -187K | -184.24K | -208.48K | 3M | 6.43M | 12.88M | 19.34M | 16.13M | 12.92M | 6.46M | n/a | n/a | n/a | n/a | n/a | 27.5K |
Financial Cash Flow | 11.61M | 10.99M | 8.84M | 9.28M | 5.02M | 6.72M | 6.72M | 6.72M | 3.22M | 12.38M | 13.49M | 24.67M | 26.66M | 14.29M | 19.17M | 7.99M | 15.2M |
Net Cash Flow | 1.33M | 2.66M | 574.28K | 837.41K | 5.14M | -4.31M | -88.82K | 9.71M | -6.03M | 9.47M | 2.9M | 4.36M | 10.05M | -4.69M | 1.07M | -8.95M | -1.15M |
Free Cash Flow | -10.66M | -12.55M | -10.43M | -8.94M | -13.62M | -14.46M | -14.46M | -14.46M | -13.46M | -13.63M | -18.63M | -20.19M | -16.48M | -18.85M | -18.08M | -17.22M | -16.63M |